Intelligence Platform

Patents

Browse 14,889 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed

patent

US 6075007

Modified noggin polypeptide and compositions

THE REGENTS OF THE UNIV. OF CALIFORNIA · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6074840

Recombinant production of latent TGF-beta binding protein-3 (LTBP-3)

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6074653

Cosmetic/dermatological w/o emulsions highly concentrated in hydroxy acids

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Tue Jun 13 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 08 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071879

Method for the treatment of bacterial infection

The Board of Regents of the University of Oklahoma · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6072072

Compounds for preparing modified hemoglobin

Montefiore Medical Center · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071955

FXR, PPARA and LXRA activators to treat acne/acneiform conditions

The Regents of the University of California · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071949

Use of lipoxygenase inhibitors as anti-cancer therapeutic and intervention agents

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071942

Elevation of circulating blood histamine levels

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071891

Insulin-like growth factor 1 receptors (IGF-1R) antisense oligonucleotide cells compositio

Regents of the University of Minnesota · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071533

Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo d

The Regents of the University of California · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071518

GP900 glycoprotein and fragments for treatment and detection/diagnosis of cryptosporidium

The Regents of the University of California · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071509

Enhanced activation of natural killer cells using an NK cell activator and a hydrogen pero

Maxim Pharmaceuticals, Inc. · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6071497

Microparticles for lung delivery comprising diketopiperazine

Pharmaceutical Discovery Corporation · Granted Tue Jun 06 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6069134

Methods and compositions comprising DNA damaging agents and p53

The Board of Regents of the University of Texas System · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6069167

Use of antioxidant agents to treat cholestatic liver disease

The Regents of the University of Technology Office of Technology Transfer · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6068990

Proteins, their production and use

Takeda Chemical Industries Ltd. · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6069140

Pharmaceutical compositions comprising texaphyrins

expired patent

US 6068843

Nucleotide sequences and methods for detection of Serpulina hyodysenteriae

BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6068816

Process for the mild reduction of germs in pharmaceutical preparations

BIONORICA ARZNEIMITTEL GMBH · Granted Tue May 30 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 25 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6066642

Dihydropyridine-, pyridine-, benzopyran-4-one- and triazoloquinazoline derivative, their p

The United States of America, as represented by the Department of Health and Human Services · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6066623

Polynucleotide vaccine protective against malaria, methods of protection and vector for de

United States of America as represented by the Secretary of the Air Force · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6066323

Use of antibodies to sialidase as anti-infectious agents and anti-inflammatory agents

The United States of America as represented by the Secretary of the Army · Granted Tue May 23 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 18 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063910

Preparation of protein microparticles by supercritical fluid precipitation

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired patent

US 6063373

Enhanced activation of NK cells using an NK cell activator and a hydrogen peroxide scaveng

Maxim Pharmaceuticals, Inc. · Granted Tue May 16 2000 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired